Lund University. For most of his career as a researcher, Lars Björck has sought to understand how bacteria manage to evade ...

Lund University. Throughout his research career, Lars Björck has been primarily interested in the interaction between ...

Professor Lars Björck, of Lund University, has been awarded the 2026 Nordic Fernström Prize. He receives the prize for his pioneering research into ...

A study has found that the immune antibody IgA, which helps protect the intestinal mucosa against bacteria and viruses, can ...

Could artificial intelligence someday design a dangerous new virus? A biotech startup is betting that if AI becomes powerful ...

Safety and efficacy results of cizutamig, an investigational B-cell maturation antigen x cluster of differentiation 3 (BCMA×CD3) T-cell engager: Interim results from a Phase 1b open-label, ...

More children are eventually getting vaccinated, but not on time. A decade of New York data reveals what's behind the growing delays and why doctors say they matter.

Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe autoimmune diseases, today ...

A clinical trial called "PARTNERS" is evaluating Infusion of MBP134, a monoclonal antibody cocktail, Infusion of Remdesivir, and Infusion of both, as a treatment for Ebola BDBV infection against ...

Beam Therapeutics is reaffirmed as a long-term buy, with significant upside expected around 2028–2029 as BEAM-302 advances.

What if your anemia treatment is fueling the rampant growth of a disease? The dangerous paradox of bioenergy hidden in the ...

With the flu spreading earlier than usual this year, market interest is growing in products that may help support immune ...